Home   Business   Article

Subscribe Now

Lonza latest pharma for Chesterford Research Park

More news, no ads


The Lonza team on their current site
The Lonza team on their current site

ing services to the pharmaceutical and biotech industries, has signed a 15-year lease of the 42,000 sq ft Gonville building, a two-winged building linked by a central reception block. The low-density development, set within 250 acres of impressive parkland, offers not only ultra-modern and energy-efficient laboratory and office space. It is within easy reach of The Nucleus central facilities building at the core of the hub.

Lonza will join a variety of established and early-stage pharma, biotech and technology research and development companies including Arecor, AstraZeneca, Cambridge Epigenetix, Charles River Laboratories, Domainex, Isogenica and Evonetix.

Yvette Stallwood, head of applied protein services at Lonza Pharma & Biotech, said: “Relocating the Cambridge site operations from Granta Park to Chesterford Research Park allows us to continue to expand our operations and services to support our customers.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More